Trends in new leprosy case detection over 57 years ( ) in Yuxi, Yunnan Province of Southwest China

Similar documents
Relapse in MB leprosy patients treated with 24 months of MDT in South West China: a short report

Rapid survey on case detection of leprosy in a low endemic situation, Zhucheng County, Shandong Province, The People s Republic of China

Occurrence and management of leprosy reaction in China in 2005

Relapse in Leprosy in Post-elimination Phase: Scenario from a Tertiary Care Center in South India

Changing Trends of Leprosy in Post Elimination Era - A Study from an Endemic Area

ORIGINAL RESEARCH ARTICLE. Access this Article Online. Website: Subject: Medical Sciences

Research Article Leprosy Reaction in Thai Population: A 20-Year Retrospective Study

Six months fixed duration multidrug therapy in paucibacillary leprosy: risk of relapse and disability in Agra PB cohort study

K Kakkad, T Padhi,K Pradhan, K C Agrawal

A Clinico Histopathological Study of Childhood Leprosy

Family motivation card: An innovative tool for increasing case detection in a resource poor setting

Early diagnosis of leprosy and the care of persons affected by the disease in a low endemic area Chen, S.

Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy

Prevalence and characteristics of neuropathic pain in the people affected by leprosy in China

Clinico-epidemiological trends of leprosy in Himachal Pradesh : a five year study

Correlation of clinical and histopathological classification of Leprosy in post elimination era

Healthcare seeking behaviour and delay in diagnosis of leprosy in a low endemic area of China

Twelve months fixed duration WHO multidrug therapy for multibacillary leprosy: incidence of relapses in Agra field based cohort study

Active surveillance in leprosy: how useful is it?

Serum beta-glucuronidase levels in children with leprosy

Basic Epidemiological Indicators for Monitoring Leprosy

JMSCR Vol 05 Issue 05 Page May 2017

Childhood leprosy in the post-elimination phase: data from a tertiary health care Hospital in the Karnataka state of south India.

REVIEW THE CHALLENGES OF MALARIA ELIMINATION IN YUNNAN PROVINCE, PEOPLE S REPUBLIC OF CHINA

Mesas Redondas / Round Tables

Trends in leprosy case detection worldwide since 1985

Research Article Postelimination Status of Childhood Leprosy: Report from a Tertiary-Care Hospital in South India

provide them regular health education to prevent deformities and disabilities.

Childhood leprosy in a tertiary-care hospital in Delhi, India: A reappraisal in the post-elimination era

Downloaded from:

International Journal of Infectious Diseases

6 months fixed duration multidrug therapy in paucibacillary leprosy: Risk of relapse and disability in Agra PB cohort study For peer review only

Bacteriological results and leprosy reactions among MB leprosy patients treated with Uniform Multidrug Therapy in China

Human Immunodeficiency Virus and Leprosy Co-infection from Pune, India

Clinico-histopathological Correlation of Leprosy in Western Region of Nepal - A Pilot Study

Rasdi Nawi. Department of Epidemiology, Faculty of Public Health, Hasanuddin University, Makassar, Indonesia

Leprosy incidence: six years follow-up of a population cohort in Bangladesh

Genital involvement and type I reaction in childhood leprosy

20 TH APRIL 2012 AT SILVER SPRING HOTEL NAIROBI

Current management of Leprosy

A Ten Year Study of Pediatric Leprosy Cases in a Tertiary Care Centre in South Kerala

Clinico-Pathological Profile of Leprosy Cases in an Institutional Setting

Childhood leprosy in an endemic area

Epidemiology of leprosy and response to treatment in Hong Kong!"#$%&'()*+,

Cancer incidence and patient survival rates among the residents in the Pudong New Area of Shanghai between 2002 and 2006

162 Biomed Environ Sci, 2014; 27(3):

Time trends in MB-PB ratio among untreated leprosy patients attending a referral hospital in UP, India during 2001 to 2010

Evidence based practice in leprosy: where do we stand?

Scenario of Histoid Hansen at a Tertiary Care Hospital in South India

A Five Year Study of Profile of Leprosy Patients attending a Tertiary Care Hospital in Manipur

The current state of leprosy control activities in Sri Lanka

The cross-sectional study of serious mental illness in Gansu province, China

Trends in prevalence and case nding in the ALERT leprosy control programme, 1979±1999

ISAAC NEERAJ SHAW, M. CHRISTIAN, K. JESUDASAN, NISHA KURIAN & GEETHA S. RAO Schieffelin Leprosy Research & Training Centre, Karigiri, India

Electrophysiological profiles of leprosy neuropathy

Increased level of urinary nitric oxide metabolites in leprosy patients during Type 2 reactions and decreased after antireactional therapy

ISPUB.COM. Clinico-Pathological Co-relation in Leprosy. B Mehta, N Desai, S Khar METHOD INTRODUCTION

Profile of Person Affected by Leprosy with Clinical Relapse among in High Endemic State of India

The National Leprosy Control Programme of Zimbabwe a data analysis,

Addition of immunotherapy to chemotherapy in pediatric borderline leprosy: a clinical evaluation

INTERNATIONAL LEPROSY CONGRESS Session: Operational issues including management of patients. Topic: Case definition and detection

The role of nerve biopsies in the diagnosis and management of leprosy

Epidemiologic and Clinical Features of Measles and Rubella in a Rural Area in China

Incidence of Leprosy Real or Relative?

Research Article The Burden of New Leprosy Cases in India: A Population-Based Survey in Two States

A REVIEW OF TREND OF LEPROSY SITUATION IN JAMNAGAR DISTRICT OF GUJARAT

Detection and Classification of Leprosy : Future Needs and Strategies

Address for correspondence: Dr. PVS Prasad, 88 AUTA Nagar, Sivapuri Post, Annamalai Nagar , Tamil Nadu, India.

Comparison of Doxycycline and Benzathine Penicillin G for the Treatment of Early Syphilis

Role of S-100 Immunostaining in Differentiation of Borderline Leprosy from Other Granulomatous Diseases of Skin

Correlation of clinical features, histopathology and demonstration of Lepra bacilli.

A study of Clinico-histopathological correlation of leprosy in a tertiary care hospital in western district of Rajasthan

A comparative evaluation of skin and nerve histopathology in single skin lesion leprosy

Enhanced active case-finding, identifying leprosy cases missed by recent detection campaigns in Munger District, Bihar, India

Epidemiology of Leprosy

Int J Clin Exp Med 2015;8(9): /ISSN: /IJCEM

Research Article WHO Multidrug Therapy for Leprosy: Epidemiology of Default in Treatment in Agra District, Uttar Pradesh, India

LEPROSY AND HIV CO-INFECTION

An institution-based observational study to identify sensitive histopathological parameters in leprosy

Incidence and Clinical Profile of Leprosy in a Tertiary Care Hospital in Hyderabad, Telangana

Epidemiological pattern of leprosy in Ethiopia: a review of the control programmes

Guidelines for Post Exposure Chemoprophylaxis with Single dose Rifampicin

The Leonine Face of Leprosy: An International Exploration

Predictive Value of Gelatin Particle Agglutination Test (GPAT) in Leprosy Detection

Attributable Causes of Cancer in China: Fruit and Vegetable

Accepted for publication 11 June Introduction

HIV/AIDS in China. -A A Potential epidemic? Kong-Lai Zhang, MD Professor, Department of Epidemiology, Peking Union Medical College Beijing, CHINA

Early diagnosis of leprosy and the care of persons affected by the disease in a low endemic area Chen, S.

Epidemiological and risk analysis of the H7N9 subtype influenza outbreak in China at its early stage

Leprosy from the Global Public Health Point of View. The Successes, Challenges, and Opportunities

Leprosy. Mycobacteriumleprae

The feature of papers and citation analysis of eleven journals in tropical medicine indexed by Science Citation Index Expanded

causes, all cancers, lung cancer and other chronic diseases in urban Shanghai.

Mesas Redondas / Round Tables

A prevalence survey on leprosy and the possible role of village lo-ceu leaders in control in Muheza District, Tanzania

Leprosy and HIV, where are we at?

2005 Update on the HIV/AIDS Epidemic and Response in China

290 Biomed Environ Sci, 2016; 29(4):

Supplementary Online Content

Findings- The sample contained participants with a mean age of 55 6 years (SD 9 7), 59 5% of whom were women. 44 7% (95% CI ) of

Transcription:

Lepr Rev (11) 8, 1 Trends in new leprosy case detection over 57 years (195 8) in Yuxi, Yunnan Province of Southwest China YU-YE LI*, XIAO-AN LI**, LI HE*, DONG WANG***,****, WEN-YING CHEN*, LIANG CHEN**, JIAN-BO LU** & YONG-GANG YAO*** *Department of Dermatology, the First Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, 53, China **Yuxi City Center for Disease Control and Prevention, Yuxi, Yunnan, 531, China ***Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, 53, China ****Graduate School of the Chinese Academy of Sciences, Beijing 139, China Accepted for publication 17 August 1 Summary Background: Leprosy control and management in China was maintained via a vertical system. Despite substantial achievements in leprosy control in the past decades, leprosy has not been completely eliminated in several endemic areas of Yunnan Province, China. Objectives: To report the epidemiological trends and management of leprosy in Yuxi, Yunnan Province from 195 to 8. Design: Diagnosis, control, and treatment data for 3 leprosy cases detected from 195 to 8 were analysed. Results: Two large-scale house-to-house surveys were launched in 1957 1958 and 194 195, and a remarkable number of new cases were identified during these two surveys. The overall prevalence rate of leprosy in the Yuxi region presented a roughly unimodal distribution between 195 and 8, with a peak (9 7 per 1 population) in 195. This reflects a combination of case detection and duration of treatment. Overall, the age distribution of the patients changed dramatically over the years, and there were only two childhood cases between 1995 and 8 (both occurring in 1998). Nearly half of the total cases (49 1%) were classified as multibacillary leprosy type. With the introduction and ubiquitous coverage of the Correspondence to: Yu-Ye Li, Department of Dermatology, the First Affiliated Hospital of Kunming Medical College, Kunming, Yunnan, 53, China (Tel/Fax: þ8-871-51885; e-mail: yyeli@yahoo.com.cn) 35-7518/11/453+11 $1. q Lepra

Trends in new leprosy case detection 7 WHO multi-drug therapy (MDT) in this area, leprosy elimination was achieved in 199. In recent years, the majority of cases (.8%) were detected by passive approaches, and there is an increasing tendency to find multibacillary leprosy patients. Conclusions: Our results provide an overall profile of our 57-year effort regarding the leprosy control in the Yuxi region. The trend in detection of new cases in recent years suggested that the transmission of leprosy has stopped in the area or, at least, dramatically declined. Introduction Leprosy is a chronic, systemic disease caused by the pathogen Mycobacterium leprae. 1 3 It affects human skin and the peripheral nerve systems, as well as eyes and other systems, resulting in a variety of disabilities associated with leprosy. 1,3,4 As an ancient disease, leprosy existed and was transmitted amongst people for at least 4 years 5 and still constitutes a public health problem today. Leprosy control in China and other countries has been successfully achieved during the past decades, 9 but it has not been eliminated in several regions according to the World Health Organization (WHO) leprosy elimination criterion (,1 case per 1 population). 1 The introduction of multi-drug therapy (MDT) against this disease since 198 had effectively reduced the number of leprosy cases. In spite of the success achieved and the decreasing annual prevalence rate, 1,8 cases worldwide were still registered at the beginning of 8. 1 In China, leprosy was highly prevalent in many prefectures in the 195s and earlier. Because of the success of the vertical approach, China achieved the goal of leprosy elimination in 1981 at country level.,11,1 The number of newly detected leprosy cases remained stable in recent years (around 14 1 cases per year). 1 There are currently around 3 leprosy patients being treated, primarily in the Yunnan, Guizhou, Sichuan, Tibet, and Hunan provinces (http://www.lepinfo.org). The Yuxi Prefecture of the Yunnan Province (north latitude 38 19 4853, longitude 118 1 138 9 ) is historically an endemic region of leprosy. It contains eight counties (Jiangchuan, Chengjiang, Tonghai, Huaning, E shan, Yimen, Xinping, and Yuanjiang) and one district (Hongta), altogether spanning an area of 15 85 km and inhabited by a considerably large population size (,1,5 individuals according to the population census data in 7) (Figure 1). The terrain of the Yuxi Prefecture is complex, with various geographic features including mountains, valleys, lakes, plateaus and basins. The whole area extends from high northwest to low southeast, and the difference of altitude between the highest and the lowest points is 81 meters. Overall, more than 8% of the area is located in hilly and mountainous regions. The Yuxi Prefecture has a subtropical plateau monsoon climate, with an average annual temperature of 15 8C 48C. Nearly 8% of residents in the Yuxi region work in agriculture; around 3% of the total population is composed of ethnic minorities including Yi, Hani, Dai etc. The leprosy control and management programme in the Yuxi Prefecture has been well maintained during the past years, firstly via a conventional vertical system and later as an integrated system, with a considerably comprehensive record for all registered patients. In this study, we report the leprosy diagnosis, control, and treatment results in Yuxi from 195 to 8, with an intention to learn more about the epidemiological trends and problems to improve disease prevention and treatment.

8 Yu-Ye Li et al. China Yunnan Yuxi Xinping (77) Yimen (3) E shan (4) Hongta (7) Jiangchuan (387) Tonghai (7) Chengjiang () Huaning (9) Yuanjiang (51) Figure 1. Map of the Yuxi Prefecture, Yunnan Province, China. The numbers in the parentheses refer to the exact number of patients in each region. Patients and Methods PATIENT DETECTION Extensive records for all leprosy cases detected in the Yuxi Prefecture were maintained at the Yuxi Center for Disease Control and Prevention. By December 31, 8, there were 39 registered leprosy cases in the Yuxi Prefecture. Among them, 14 cases were detected during 1918 1951; these cases did not have sufficient clinical information and were excluded from the current analysis. Additionally there was no systematic field investigation on leprosy before 195 in the Yuxi region. Between 195 and 198, an active case detection strategy was widely carried out. These active strategies include house-to-house surveys, physical examinations for cured patients, household contacts of confirmed leprosy patients, and the clue survey, by which professional health workers collected and confirmed leprosy patients in the area according to the information provided by rural paramedical workers. There were two massive campaigns of active case detection strategy in which house-to-house searches were performed in the Yuxi Prefecture: from the end of 1957 to 1958 and the end of 194 to 195. In recent years, case detection was mainly passive through voluntary reporting centers and self-reporting. CASE DEFINITION We diagnosed leprosy patients based on clinical and histopathological features, as well as the bacteriological index if available. Because of the classification systems, terms and

Trends in new leprosy case detection 9 definitions of leprosy have evolved over the past decades, so we followed the strategy of Chen et al. and grouped the cases into multibacillary (MB) leprosy and paucibacillary (PB) leprosy. In brief, lepromatous (L) and borderline (B) leprosy in the Madrid classification and lepromatous (LL), borderline-lepromatous (BL) and mid-borderline (BB) in the Ridley Jopling classification were classified as multibacillary (MB) leprosy. Tuberculoid (T) leprosy in the Madrid classification, indeterminate (I) in both classifications, and tuberculoid (TT) and borderline-tuberculoid (BT) in the Ridley Jopling classification were grouped as paucibacillary (PB) leprosy. The number of skin lesions, 1 5 for PB and.5 for MB according to the WHO operational classification 3 was also considered during the classification of patients. For patients that were recorded in the 195s and 19s, we re-evaluated the original related clinical, bacteriological, and histopathological profiles (if applied) and classified these patients according to the current classification system. Disability levels were graded according to the revised WHO grading system. 13 Similarly, for those patients who were registered before the agreement of the current grading system, we re-evaluated their originally recorded disability grades based on the newer WHO criteria. Relapse after treatment was defined according to the WHO guide to leprosy control, despite the fact that there may be confusion regarding re-infection and relapse. 14 All the computerised data were analysed by using SPSS 13. (SPSS Inc., Chicago, Illinois). The institutional review boards of the Yuxi City Center for Disease Control and Prevention, the First Affiliated Hospital of Kunming Medical College, and the Kunming Institute of Zoology approved this study. Prevalence/Case detection rate (per 1 ) 1 9 8 7 5 4 3 1 A shift of DDS to DDS + RFP as the main cure method Coverage of the MDT Prevalence rate Case detection rate MDT coverage 1 9 8 7 5 4 3 1 Multidrug therapy coverage (%) 195 1954 195 1958 19 19 194 19 198 197 197 1974 197 1978 198 198 1984 198 1988 199 199 1994 199 1998 4 8 Year Figure. Prevalence and case detection rate of leprosy and MDT coverage in the Yuxi Prefecture during 195 8.

Table 1. Leprosy case detection, prevalence and related information in Yuxi, Yunnan, China, 195 8 1 Year Case detection Prevalence Population Size No. Rate* No. Rate* Male/ Female Children (,15 yr) Nationality Method of Detection Classification Disability Treatment No. Proportion (%) Han Yi Other Age at diagnosis (yr) Delay detection (yr) Active Passive Unclear PB MB I II Unclear DDS DDS þ RFP MDT Other 195 91,1 5 17 1 95 35/1 15 79 49 5 4,, 31 39 1 1 7 9 1 35 55 1 1953 977,41 49 5 1 34/15 1 41 39 4 1, 48, 13 3 7 3 1 1 7 48 1 1954 993,53 31 31 44 4 5/ 45 5 8,, 19 7 4 17 14 7 9 1955 994,9 4 4 71 73 17/7 4 1 7 19 5 8,, 11 1 1 1 1 9 1 14 1 3 195 1,4,179 48 48 315 3 14 3/18 9 18 75 33 1 5 9, 5, 44 3 1 1 7 1 5 33 4 1957 1,3,31 5 48 359 3 48 35/15 7 14 33 14 3 5, 3, 7 44 7 3 14 3 33 47 3 1958 1,1,5 15 1 5 5 53 173/4 1 33 15 4 4 5, 75, 3 175 1 39 1 95 7 9 17 3 189 1959 995,1 3 44/1 1 1 13 39 17 4 7, 58, 1 54 1 5 37 3 1 11 8 49 11 19 97,1 8 48 4 4/ 1 15 15 51 13 9, 3, 17 39 4 3 44 37 7 191 98,15 37 38 8 7 /11 4 1 81 7 8 11, 47, 8 7 3 7 3 14 9 5 3 31 19 983,449 43 44 98 7 1 34/9 14 9 31 8 4 4, 5, 13 34 7 9 14 18 1 4 34 9 193 1,3,9 5 51 74 7 9 44/8 4 7 9 4 7 5 1, 8, 4 5 3 34 1 17 49 3 194 1,4,3 43 4 77 7 9 33/1 7 1 8 3 1 1 9,, 14 39 4 8 15 18 3 3 7 195 1,98,51 1 38 118 9 7 18/75 11 4 3 44 1 1 5, 7, 37 49 8 4 141 1 74 37 15 48 13 19 1,134,744 5 44 15 9 5 41/9 11 7 38 11 1 1, 4, 1 43 1 33 17 13 7 3 47 3 197 1,158,57 34 9 143 9 8/ 3 8 57 9 3 11, 54, 13 3 4 1 13 9 9 1 3 198 1,,43 51 4 15 8 8 4/9 5 9 8 41 8 11, 53, 1 4 7 3 19 4 1 47 4 199 1,5,984 1 17 14 8 9 17/4 1 4 7 1 3 1, 3, 11 14 3 4 11 1 8 5 8 18 3 197 1,7,79 83 5 17 8 43 3/ 4 4 8 58 3 1, 73, 8 5 1 43 4 13 44 3 1971 1,334,44 4 3 181 8 1 3/8 3 4 1, 7, 1 31 7 5 15 14 5 1 3 8 197 1,37,78 7 49 191 7 9 5/11 3 4 55 51 9 7 7, 4, 1 7 39 8 18 15 34 47 1973 1,49,7 3 174 7 31/5 1 78 8 5 3 1, 74, 14 4 4 1 15 3 18 3 1974 1,443,84 34 4 137 7 18 3/11 4 8 1, 77, 15 3 1 1 13 1 11 5 18 9 5 1975 1,477,971 33 14 79 8/5 1 3 3 4 9 1, 8, 14 8 3 3 1 14 9 1 3 3 197 1,58,149 7 18 94 39 /5 1 3 7 19 14, 4, 18 1 4 1 11 9 7 11 4 3 1977 1,54,713 3 19 95 /4 7 19 7 4 13, 9, 18 1 3 17 13 9 15 5 5 1978 1,5,88 47 3 94 1 38/9 38 5 4 19, 3, 3 4 1 8 19 1 1 1 4 5 1979 1,583,47 8 18 93 5 83 17/11 1 3 57 7 1 14, 71, 4 5 1 13 15 5 17 14 14 198 1,59,4 5 35 897 5 39/17 5 8 93 3 17 3 8, 7, 5 5 5 1 31 5 7 3 8 1981 1,15,15 35 871 5 39 /13 5 71 4 5 11,, 5 9 5 1 1 19 11 7 17 15 198 1,33,1 43 794 4 8 34/9 4 5 3 11 1, 7, 4 9 14 3 14 13 1 18 5 1983 1,49,83 13 54 3 9 17/5 1 7 3 17, 4, 18 14 8 8 14 9 7 11 11 1984 1,7,1 33 394 3 /11 3 9 9 1 7 5 1, 83, 1 19 14 1 3 13 9 1 1 9 4 1985 1,88,97 1 1 39 1 95 14/7 1 8 1 15, 7, 15 3 18 7 4 9 1 3 18 198 1,71,39 15 38 1 39 / 4 1 1 17, 1, 8 1 14 9 17 15 1 9 1 4 1987 1,739,8 9 17 18 1 7 1/8 1 3 45 19 7 3, 7, 14 3 14 15 9 3 17 7 1988 1,7,938 4 15 88 37/9 1 17 34 8 4 14, 81, 18 9 37 17 9 1 9 1 4 39 3 1989 1,78,943 33 19 18 95 3/1 1 1 15, 71, 17 5 8 1 3 1 9 1 3 1 199 1,794,5 38 1 181 1 1 9/9 4 1 81 5 1 3 9, 8, 11 8 3 15 3 1 8 9 38 1991 1,818,113 14 191 1 5 / 4 15 38 19 7 8,, 1 1 1 4 1 4 1 199 1,838,75 1 9 153 83 13/3 11 5 17, 85, 15 3 13 8 8 9 4 3 1 1993 1,85,439 18 1 19 7 13/5 1 5 5 15 1, 5, 4 3 15 1 17 11 1 3 1 3 1994 1,871,945 14 7 88 47 9/5 14 9 8 5 1 1, 9, 1 1 3 11 8 1 5 13 1 1995 1,885,3 1 5 5 34 5/5 7 1, 1, 5 1 8 9 1 1 199 1,94,778 15 8 5 7 11/4 14 1 1,, 14 13 4 11 9 4 15 Yu-Ye Li et al.

Table 1. continued Case detection Prevalence Children (,15 yr) Nationality Method of Detection Classification Disability Treatment Year Population Size No. Rate* No. Rate* Male/ Female No. Proportion (%) Han Yi Other Age at diagnosis (yr) Delay detection (yr) Active Passive Unclear PB MB I II Unclear DDS DDS þ RFP MDT Other 1997 1,935,441 17 9 7 3 14/3 1 4 1 15, 71, 4 4 13 4 13 1 5 15 1998 1,94,349 1 87 45 1/4 1 15 3 1, 79, 3 9 11 5 15 9 5 19 1 1999 1,971,7 11 9 47 /5 3, 9, 7 1 1 11 3 11 1,991,34 1 5 8 41 /4 7 1 1, 5, 9 1 9 3 7 3 5 1 1,1,78 9 4 53 8/1 3 5, 7, 9 7 4 3 9,34,5 8 4 5 5 5/3 5 3 31,, 4 4 3 5 3 4 1 8 3,53,957 3 41 /4 4 1 1 18, 54, 5 1 5 4 4,8,473 9 4 3 17 8/1 7 1 1 3, 9, 4 1 8 1 8 4 3 9 5,85,53 4 38 18 1/3 4 9, 43, 7 4 3 1 4,91,49 5 34 1 3/ 1 19, 54, 17 1 4 5 3 1 1 5 7,1,14 13 37 18 8/5 9 4 1, 77, 3 13 11 4 1 7 1 13 8,1,5 14 7 4 1/4 8 4 1, 4, 4 4 1 8 5 4 5 14 Note: *The case detection rate and the prevalence rate are expressed per 1. Aggregation of these patients belong to Dai, Hui, Hani, Miao, Mongolian, Bai and Zhuang ethnic groups. Patients with unclear information. Patients who received treatment with traditional Chinese medicine or other drugs. Trends in new leprosy case detection 11

1 Yu-Ye Li et al. Results From 195 to 8, a total of 3 leprosy cases were detected in the Yuxi Prefecture. The overall prevalence rate of leprosy in the Yuxi region presents a roughly unimodal distribution between 195 8, with a peak (9 7 per 1 population) in 195 (Figure and Table 1). More than 95% of cases were of farmers living in impoverished, rural areas. This pattern reflects the population of the area, in which 8% of residents in the Yuxi region belong to the agricultural population. The majority of the cases are Han Chinese (18/3, 75 %), followed by the Yi ethnic group (49/3, 19 3%); the remaining cases (1/3, 5 7%) are composed of individuals from the Hani, Hui, Dai, Miao, Mongolian, Bai, and Zhuang ethnic groups. There is a higher prevalence of disease in males (13/3; 74 8%) than in females (5/3; 5 %). Among all cases, 48 1% had a disability of and 14 1% of 1; the remaining cases had no disabilities associated with leprosy. Due to the delayed detection and treatment of the disease, patients of older age had a higher chance of relapse and disability of than younger ones. This pattern was generally consistent with the result of a national survey conducted in China between 1984 and 1998. 15 Nearly half of the 3 cases were MB leprosy (49 1%) at the time of diagnosis. The proportion of MB patients among the annually detected cases was remarkably high (.%; with the exception of 1987, 199, and 5) since 1983 (Table 1). We observed a significant decrease of the prevalence rate to an average level of 47 per 1, population during 1988 8 (Figure 1). Concomitant with this decrease is the introduction of the WHO MDT treatment in 1988 which extended completely throughout the Yuxi Prefecture (excluding the years 1991 and 1993, in which 9 % and 83 3% coverage was achieved, respectively). A total of 331 cases have received MDT treatment so far and none of them relapsed. Accompanying the full delivery of MDT service, a high proportion of new cases (.8%, with a few years in exception) were detected by passive, instead of active approaches (Table 1). The average age at diagnosis of the patients was 7 7 ^ 13 7 years, whereas the delay between the estimated onset of leprosy symptoms and confirmed diagnosis was 3 9 ^ 5 years. Note that the delayed detection time estimated here might not be reliable, as the information was based on each patient s recall. One hundred and seventy-six cases detected during 195 8 were of children (, 15 years old). The overall age distribution of the patients has changed dramatically over the years, and there were no childhood cases among the newly diagnosed cases during 1995 to 8 (except for two in 1998) (Table 1). The absence of childhood cases in recent years might mean that transmission has stopped in the area or, at least, dramatically declined. Discussion The final eradication of leprosy is a long process despite a successful fight against this disease in recent decades. The complete coverage of WHO MDT treatment and the integration of conventional vertical leprosy services into the general health care services in recent years have brought important changes for the leprosy control and management programme. To investigate the recent epidemiological trends of leprosy under these changes will provide useful information for the continual surveillance of leprosy. In this study, we summarise our 57-year efforts on leprosy control and management in the Yuxi Prefecture of

Trends in new leprosy case detection 13 Yunnan Province. Our current study complements previous reports regarding leprosy in China,,7,11,1,15 4 especially on the recent trends of leprosy in the Yuxi region. The leprosy elimination goal was achieved in 199 in the Yuxi Prefecture. The long fight against leprosy in this region can be separated into three periods based on the different principal therapeutic approaches that were employed. During the first period (195 1981), the prevalence rate was very high, with an average value of 3 per 1 population. The increase in prevalence of cases from 195 until the mid 19s reflects a combination of case detection and duration of treatment. During the two large-scale campaigns of active case detection (the end of 1957 to 1958 and the end of 194 to 195) in the Yuxi Prefecture, when house-to-house searches were performed, a large number of patients were detected, Dapsone (DDS) monotherapy was used as the main approach to cure leprosy, with a small portion of cases being treated with DDS þ rifampin (RFP) and/or traditional Chinese medicine. Following DDS treatment, the overall relapse rates in the Yuxi region were relatively low for MB (5 51%) and PB ( 81%) cases. Our result was in general concordance with a previous nationwide survey of the leprosy relapse rates in patients treated by DDS 17 : MB patients (8 14% or 5 91 per 1 patient-years (PY) over an average follow-up period of 13 8 ^ 8 4 years); PB patients (1 5% or 8 per 1 PY over an average period of 14 5 ^ 8 9 years). 17 During the second period (198 1988), DDS þ RFP was widely used to cure patients. Especially in the last two years, this treatment was ubiquitous in the Yuxi region. Corresponding with the expansion of the DDS þ RFP treatment, the prevalence rate of leprosy was dramatically decreased, averaging per 1 population. We observed fewer cases with relapse (5 %) compared to those who received the DDS treatment in the first period. The third period started with the introduction of the WHO MDT treatment in 1988. The quick widespread coverage of MDT caused a dramatic decline of the prevalence rate to 45 per 1 population. Remarkably, there have been no childhood cases since 1995 until now (excluding the two childhood cases detected in 1998), suggesting that leprosy transmission has been well controlled in the area in recent years. None of the cases treated with MDT treatment in the Yuxi Prefecture relapsed during the follow-up surveillance. The overall relapse rate in our patients treated with MDT was similar to that of a retrospective relapse survey by Shen et al., in which they also found a low relapse rate ( 1/1 personyears). The lower relapse rate in the Yuxi Prefecture may be due to better management of the patients during the MDT treatment and all patients completed treatment. Although the WHO MDT treatment was the most effective method to control leprosy in the Yuxi region, there are several features to consider when implementing management policies for leprosy in the future. Firstly, the prevalence rate and casedetection rate had already declined before the introduction of MDT and seemingly reached a plateau in recent years. This pattern is consistent with previous reports, 8,1,5 suggesting that the previous leprosy control strategy and management was essentially useful for disease control. Secondly, corresponding with ubiquitous coverage in Yuxi, more MB cases were detected. The proportion of MB patients among the new cases (73 4%) detected between 1988 and 8 was significantly higher than the proportion detected (4 8%) from 195 to 1987. This change of leprosy epidemiology may deserve special attention in future disease control. Thirdly, we noticed several differences regarding the prevalence rate and the proportion of MB or PB leprosy in the nine counties of the Yuxi Prefecture (Figure ). The Hongta, Jiangchuan, and Tonghai counties had a higher proportion of younger patients (, years old), whereas Yimen and Xinping counties had a considerably high

14 Yu-Ye Li et al. PB patient MB patient Number of patients 9 8 7 5 4 3 1 1 9 8 7 5 4 3 1 1 1 8 4 1 35 Chengjiang 1 Hongta 3 Xinping 8 5 44 39 48 15 7 4 18 3 1 8 7 7 35 3 5 15 13 31 1 5 4 1 18 3 15 7 7 5 5 3 7 5 13 11 8 3 <1 1- -3 3-4 4-5 5- > <1 1- -3 3-4 4-5 5- > <1 1- -3 3-4 4-5 5- > 14 1 E shan 1 Jiangchuan 14 Yuanjiang 1 1 5 9 55 8 1 9 51 8 5 4 34 8 1 1 4 55 1 7 3 5 34 34 45 7 1 4 3 1 13 8 3 1 9 3 4 1 1 1 <1 1- -3 3-4 4-5 5- > <1 1- -3 3-4 4-5 5- > <1 1- -3 3-4 4-5 5- > 1 1 Huaning Tonghai Yimen 1 1 37 8 41 8 58 5 7 31 49 39 4 17 4 59 14 31 35 37 1 5 7 35 43 31 11 33 15 15 1 17 1 1 3 5 1 1 <1 1- -3 3-4 4-5 5- > <1 1- -3 3-4 4-5 5- > <1 1- -3 3-4 4-5 5- > Figure 3. Distribution and classification of the leprosy cases in the Yuxi Prefecture. Patients were classified into multibacillary (MB) and paucibacillary (PB) leprosy groups according to the latest definition of the terms applied to the original medical records. Age proportion (1 81%) of patients more than 5 years old. Additionally the Huaning and Tonghai counties had more MB than PB patients (Huaning, 59 59% vs 4 41%; Tonghai, 58 9% vs 41 91%) (Figure 3). Delay in the detection of new cases was one of the major reasons for serious deformities and damage caused by leprosy. There are many factors that may affect case detection and rehabilitation. 15,7 Early detection is an important way to avoid the higher grade of disability. The average delay in detection rate was 3 91 ^ 5 years in all Yuxi cases, and it declined to 1 8 ^ 3 77 years in the third period of leprosy control in this region. In 5 and 8, the overall delayed detection time was unexpectedly long. The associated disabilities of these late-diagnosed patients is not negligible as we observed a higher proportion of cases (. %) with deformities at or even more severe (Table 1). Thoroughness in early detection and treatment will be essential to avoid high rates of deformity. Most cases detected during the third period of leprosy control in the Yuxi region (from 1988 to 8) were by passive approaches, which suggests that detection of cases through dermatological clinics and/or voluntary medical examination would be the main source for new case detection in the future. Leprosy education and disease diagnosis training for local clinicians and the public is undoubtedly essential for the ultimate goal of leprosy eradication. In summary, we report here our 57-year efforts on leprosy control and management in the Yuxi Prefecture of Yunnan Province. The emerging features of the epidemiological trends of

Trends in new leprosy case detection 15 leprosy in recent years in this region deserve special attention, especially for disease monitoring and management, and case-detection. Our fight against this ancient disease is promising and will not cease. Acknowledgements We thank the leprosy workers and clinicians in the Centers of Disease Control and Prevention of the Yuxi Prefecture for their excellent assistance in collecting data. We also thank the patients for their participation in this study, the two anonymous reviewers for their critical reading of the early version of the manuscript, and Miss Diana Chen for language editing. X.-A. L. was supported by the Yuxi city (8-938). Y.-G. Y. was supported by Yunnan Province (9CI119), Chinese Academy of Sciences and the National Science Foundation of China (3951). References 1 Britton WJ, Lockwood DN. Leprosy. Lancet, 4; 33: 19 119. Alter A, Alcaïs A, Abel L et al. Leprosy as a genetic model for susceptibility to common infectious diseases. Hum Genet, 8; 13: 7 35. 3 Walker SL, Lockwood DN. Leprosy. Clin Dermatol, 7; 5: 15 17. 4 Kumar B, Dogra S. Leprosy: a disease with diagnostic and management challenges! Indian J Dermatol Venereol Leprol, 9; 75: 111 115. 5 Robbins G, Tripathy VM, Misra VN et al. Ancient skeletal evidence for leprosy in India ( B.C.). PLoS ONE, 9; 4: e59. Chen XS, Li WZ, Jiang C et al. Leprosy in China: epidemiological trends between 1949 and 1998. Bull World Health Organ, 1; 79: 3 31. 7 Shen J, Liu M, Zhou M. Current situation of leprosy colonies/leprosaria and their future in P.R. China. Lepr Rev, 7; 78: 81 89. 8 Groenen G. Trends in prevalence and case finding in the ALERT leprosy control programme, 1979 1999. Lepr Rev, ; 73: 9 4. 9 Koba A, Ishii N, Mori S et al. The decline of leprosy in Japan: patterns and trends 194 8. Lepr Rev, 9; 8: 43 44. 1 WHO. Global leprosy situation, beginning of 8. Wkly Epidemiol Rec, 8; 83: 93 3. 11 Ye G. Leprosy control in China. Achievements and prospect. Chin Med J (Engl), 1995; 18: 43 44. 1 Shen JP, Gupte MD, Jiang C et al. Trends of case detection and other indicators of leprosy in China during 1985. Chin Med Sci J, 5; : 77 8. 13 WHO. WHO expert committee on leprosy. Sixth report. Geneva. (WHO technical report series, no. 78). 1998. 14 Kaimal S, Thappa DM. Relapse in leprosy. Indian J Dermatol Venereol Leprol, 9; 75: 1 135. 15 Chen XS, Li WZ, Jiang C et al. Leprosy in China: delay in the detection of cases. Ann Trop Med Parasitol, ; 94: 181 188. 1 Chen XS, Li WZ, Jiang C et al. Studies on risk of leprosy relapses in China: relapses after treatment with multidrug therapy. Int J Lepr Other Mycobact Dis, 1999; 7: 379 387. 17 Chen XS, Li WZ, Jiang C et al. Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy. Int J Lepr Other Mycobact Dis, 1999; 7: 371 378. 18 Chen XS, Li WZ, Jiang C et al. Leprosy in children: a retrospective study in China, 198 1997. J Trop Pediatr, ; 4: 7 11. 19 Chen XS, Li WZ, Jiang C et al. Studies on mode of detection of leprosy in China during the years 1981 1998. Lepr Rev, 1; 7: 3 31. Chen XS, Li WZ, Jiang C et al. Computerization of leprosy records: national leprosy recording and reporting system in China. Lepr Rev, ; 71: 47 5. 1 Ma HD, Ye GY, Shu HW et al. Studies on social medicine and leprosy in east China. Proc Chin Acad Med Sci Peking Union Med Coll, 1989; 4: 1 4. Shen J, Liu M, Zhang J et al. Relapse in MB leprosy patients treated with 4 months of MDT in south west China: a short report. Lepr Rev, ; 77: 19 4.

1 Yu-Ye Li et al. 3 Shen J, Liu M, Zhou M et al. Occurrence and management of leprosy reaction in China in 5. Lepr Rev, 9; 8: 14 19. 4 Liu D, Li G, Huang W et al. Analysis of newly detected leprosy cases and misdiagnosis in Wuhan (199 4). Lepr Rev, 9; 8: 41 415. 5 WHO. Leprosy control in Thailand: trends in case detection, 195 5. Wkly Epidemiol Rec,7;8: 1 71. Kumar A, Girdhar A, Girdhar BK. Nerve thickening in leprosy patients and risk of paralytic deformities: a field based study in Agra, India. Lepr Rev, 4; 75: 135 14. 7 Withington SG, Joha S, Baird D et al. Assessing socio-economic factors in relation to stigmatization, impairment status, and selection for socio-economic rehabilitation: a 1-year cohort of new leprosy cases in north Bangladesh. Lepr Rev, 3; 74: 1 13.